Apellis Pharmaceuticals, Inc. - COM (APLS)

Historical Portfolio Holders from Q4 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
110 M
Holdings value Q1 2024
$6.48 B
Value change Q1 2024
-$5.92 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
285
Number of buys Q1 2024
160
Number of sells Q1 2024
-130
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.003%
CUSIP
03753U106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 110 M $6.48 B -$5.92 M $58.78 285
2023 Q4 110 M $6.6 B -$35.3 M $59.86 280
2023 Q3 112 M $4.27 B -$265 M $38.04 254
2023 Q2 105 M $9.59 B -$396 M $91.10 313
2023 Q1 110 M $7.26 B +$675 M $65.96 273
2022 Q4 98.2 M $5.08 B +$27.4 M $51.71 234
2022 Q3 93.2 M $6.36 B +$1.2 M $68.30 244
2022 Q2 91.4 M $4.13 B +$32.7 M $45.22 201
2022 Q1 90.9 M $4.62 B +$518 M $50.81 208
2021 Q4 81 M $3.83 B +$612 M $47.28 182
2021 Q3 68.6 M $2.26 B -$120 M $32.96 173
2021 Q2 64.6 M $4.08 B +$9.8 M $63.20 201
2021 Q1 65 M $2.79 B +$19.9 M $42.91 172
2020 Q4 63.8 M $3.65 B -$9.73 M $57.20 164
2020 Q3 61.7 M $1.86 B +$25.5 M $30.17 139
2020 Q2 61 M $1.99 B +$171 M $32.66 134
2020 Q1 54.1 M $1.45 B +$293 M $26.79 141
2019 Q4 43.3 M $1.32 B +$86.1 M $30.62 135
2019 Q3 40.3 M $972 M +$45.9 M $24.09 126
2019 Q2 40.4 M $1.02 B +$14.3 M $25.34 96
2019 Q1 40.1 M $782 M +$161 M $19.50 91
2018 Q4 32 M $423 M -$27.5 M $13.19 92
2018 Q3 29.7 M $528 M +$9.56 M $17.78 77
2018 Q2 29.1 M $639 M +$267 M $22.00 71
2018 Q1 17 M $375 M +$8.76 M $22.11 46
2017 Q4 15.7 M $340 M +$340 M $21.70 46